Citagenix
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3300 Autoroute Jean-Noël-Lavoie a-440 O,...Phone Number
(947) 570-1122Website
www.citagenix.comRevenue
<$5 MillionIndustry
About Citagenix
Citagenix Org Chart
Is Citagenix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Citagenix recently announced quarterly report
Check if Citagenix has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Citagenix launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Citagenix has new funding data
Citagenix, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Citagenix
Check out if Citagenix is spiking on competitors!
Click to see if Citagenix had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Citagenix
Find 2 more new buyers
Compare Similar Companies to Citagenix
Compare insights from companies similar to Citagenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Citagenix is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Citagenix is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Citagenix.
Citagenix Tech Stack
A closer look at the technologies used by Citagenix
Citagenix News & Media
Antibe Therapeutics Receives Approval to Initiate Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346
TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Receives Approval to Initiate Part One of Phase 2B Dose-Ranging, Efficacy Study for ATB-346Antibe Therapeutics Announces Grant of Restricted Share Units
TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS ANNOUNCES GRANT OF RESTRICTED SHARE UNITSAntibe Therapeutics Announces Strategic Licensing Deal for Lead Drug in South Korea
TORONTO, Ontario--(BUSINESS WIRE)--ANTIBE THERAPEUTICS ANNOUNCES STRATEGIC LICENSING DEAL FOR LEAD DRUG IN SOUTH KOREA. License includes C$13 million in non-dilutive milestone payments and a double-digit royalty to Antibe.Antibe Therapeutics Reports Q1 2019 Interim Financial and Operating Results
TORONTO--(BUSINESS WIRE)--ANTIBE THERAPEUTICS REPORTS Q1 2019 INTERIM FINANCIAL AND OPERATING RESULTS
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Citagenix
Citagenix Regen LLC specializes in providing innovative and high-quality dental regenerative biomaterials, including bone grafts, barrier membranes, and wound dressings. Their products are designed to enhance bone healing and regeneration, catering primarily to dental surgeons, periodontists, and implant dentists. With a commitment to excellence si... Read More